Physician profile
Amy Estes
NPI 1790908663
$2,346.29
in general payments reported to CMS, 2019-2025
16 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $145 · 2021: $140 · 2022: $315 · 2023: $361 · 2024: $505 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $629.64 | 2019-2024 | Clareon, Rocklatan |
| Glaukos Corporation | $337.04 | 2021-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Oyster Point Pharma, INC. | $319.03 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $194.12 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $166.61 | 2020-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $146.65 | 2023 | Tecnis Simplicity |
| Dompe US, INC. | $137.44 | 2022-2024 | Oxervate |
| Shire North American Group INC | $121.62 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.86 | 2019 | |
| Amgen INC. | $52.36 | 2024 | Tepezza |
| Bausch & Lomb Americas INC. | $42.24 | 2024-2025 | Miebo, Xiidra |
| Carl Zeiss Meditec Cataract Technology INC. | $36.40 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $16.79 | 2019 | |
| Kala Pharmaceuticals, INC. | $14.87 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.